BioSpace News Archive

James P. Allison will helm an innovation hub at The University of Texas MD Anderson Cancer Center that is focused on developing new immunotherapy breakthroughs in oncology.

Novavax announced today that its protein-based Covid-19 vaccine, NVX-CoV2373, is included in two new clinical trials that will evaluate the vaccine as a potential Covid booster.

Seattle-based Icosavax’s stock plunged 50% after the company reported topline interim data from its ongoing Phase I/II COVID-19 vaccine trial.

The FDA has a very busy week ending the month of March and moving into April, highlighted by a big AdCom vote on Amylyx’s ALS candidate AMX0035 on March 30.

Sensorion is pleased to announce the participation of Sensorion’s CEO, Nawal Ouzren, in the H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference, an investor meeting being held on March 30th, 2022.

ANGLE plc, a world-leading liquid biopsy company, is pleased to announce that a leading cancer research institute, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, has published results of a study undertaken in early stage triple negative breast cancer patients undergoing neoadjuvant chemotherapy.

Faron Pharmaceuticals Ltd announced audited full-year financial results for January 1 to December 31, 2021 and H2 2021 and provided an overview of recent corporate developments.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, reported its full year 2021 operating and financial results.

Fennec Pharmaceuticals Inc. announced that the Company will be participating in the 2022 Maxim Group Virtual Growth Conference, taking place March 28-30, 2022.

Renalytix plc announced the Company will release its second quarter and first half fiscal year 2022 financial results on Thursday, March 31, 2022, before market open.